pentazocine has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, R; Luedtke, RR; Mach, RH; Perez, E; Simpkins, JW; Tu, Z; Vangveravong, S; Yang, SH | 1 |
| Hashizume, M; Matsuoka, Y | 1 |
2 other study(ies) available for pentazocine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Neuroprotective effects of high affinity Σ1 receptor selective compounds.
Topics: Acetamides; Animals; Antipsychotic Agents; Female; HEK293 Cells; Humans; Infarction, Middle Cerebral Artery; Mice; Neuroprotective Agents; Pentazocine; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, sigma; Sigma-1 Receptor; Treatment Outcome | 2012 |
Moyamoya disease in which pentazocine treatment caused cerebral infarction.
Topics: Adult; Analgesics, Opioid; Cerebral Angiography; Hematoma; Humans; Infarction, Middle Cerebral Artery; Injections, Intramuscular; Magnetic Resonance Angiography; Male; Moyamoya Disease; Patient Admission; Pentazocine; Perineum; Scrotum; Tomography, X-Ray Computed | 2010 |